2015 年
1. Seri Y, Shoda H, Suzuki A, Matsumoto I, Sumida T, Fujio K, Yamamoto K.:
Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate
isomerase-induced arthritis model.
Sci Rep 5:13041,2015
2. Takahashi H, Tsuboi H, Abe S, Yokosawa M, Hagiwara S, Asashima H, Hirota T, Umeda N, Kondo
Y, Matsumoto I, Sumida T.:
Magnetic resonance imaging can reveal fascial vasculitis in a patient with microscopic polyangiitis.
Scand J Rheumatol 44(6):511-513,2015
3. Murayama MA, Kakuta S, Inoue A, Umeda N, Yonezawa T, Maruhashi T, Tateishi K, Ishigame H,Yabe R, Ikeda S, Seno A, Chi HH, Hashiguchi Y, Kurata R, Tada T, Kubo S, Sato N, Liu Y, Hattori
M, Saijo S, Matsushita M, Fujita T, Sumida T, Iwakura Y.:
CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis.
Nat Commun 25;6:8483,2015
4. Nakajima A, Masaki Y, Nakamura T, Kawanami T, Ishigaki Y, Takegami T, Kawano M, Yamada K,Tsukamoto N, Matsui S, Saeki T, Okazaki K, Kamisawa T, Miyashita T, Yakushijin Y, Fujikawa K,Yamamoto M, Hamano H, Origuchi T, Hirata S, Tsuboi H, Sumida T, Morimoto H, Sato T, Iwao H,Miki M, Sakai T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H.:
Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells fromPatients with IgG4-Related Disease.
PLoS One 10(5):e0126582,2015
5. Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D,Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda
A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A; Musashi Study Investigators.:
Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy inPatients With Rheumatoid Arthritis.
Arthritis Care Res 67(10):1354-1362,2015
6. Yoon JH, Sudo K, Kuroda M, Kato M, Lee IK, Han JS, Nakae S, Imamura T, Kim J, Ju JH, Kim DK,Matsuzaki K, Weinstein M, Matsumoto I, Sumida T, Mamura M.:
Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in
TH17 differentiation.
Nat Commun 6:7600,2015
7. Asashima H, Tsuboi H, Takahashi H, Hirota T, Iizuka M, Kondo Y, Matsui M, Matsumoto I, SumidaT.:
The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses
experimental sialadenitis-like Sjögren's syndrome.
Arthritis Rheum 67(8):2213-2225,2015
8. Miki H, Nakahashi-Oda C, Sumida T, Shibuya A. Involvement of CD300a PhosphatidylserineImmunoreceptor in Aluminum Salt Adjuvant-Induced Th2 Responses.
J Immunol 194(11):5069-5676,2015
9. Kondo Y, Yao Z, Tahara M, Iizuka M, Yokosawa M, Kaneko S, Segawa S, Tsuboi H, Yoh K,Takahashi S, Matsumoto I, Sumida T.:
nvolvement of RORγt-overexpressing T cells in the development of autoimmune arthritis in mice.
Arthritis Res Ther 17(1):105,2015

10. Takai C, Matsumoto I, Inoue A, Umeda N, Tanaka Y, Kurashima Y, Wada Y, Narita I, Sumida T.:
Specific overexpression of tumour necrosis factor-α-induced protein (TNFAIP)9 in CD14(+) CD16(-)
monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3.
Clin Exp Immunol 180(3):458-466,2015
11. Kurata I, Tsuboi H, Takahashi H, Yagishita M, Abe S, Ebe H, Takahashi H, Asashima H, Hirota T,Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus successfully treated bycorticosteroid and methotrexate.
Rheumatology (Oxford) 54(7):1160,2015
12. Takahashi H, Tsuboi H, Ogishima H, Yokosawa M, Takahashi H, Yagishita M, Abe S, Hagiwara S,Asashima H, Hirota T, Umeda N, Kondo Y, Suzuki T, Matsumoto I, Sumida T.:[18F]fluorodeoxyglucose positron emission tomography/computed tomography can reveal subclinicalprostatitis in a patient with IgG4-related disease.
Rheumatology (Oxford) 54(6):1113,2015
13. Kurata I, Tsuboi H, Takahashi H, Abe S, Ebe H, Hagiwara S, Umeda N, Kondo Y, Ogishima H,Suzuki T, Matsumoto I, Hoshi S, Oshika T, Sumida T.:
Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's
Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis.
Intern Med 54(12):1553-1557,2015
14. Iizuka M, Tsuboi H, Matsuo N, Asashima H, Hirota T, Kondo Y, Iwakura Y, Takahashi S, Matsumoto
I, Sumida T.:
A crucial role of RORγt in the development of spontaneous Sialadenitis-like Sjögren's syndrome.
J Immunol 194(1):56-67,2015
15. Furukawa S, Moriyama M, Tanaka A, Maehara T, Tsuboi H, Iizuka M, Hayashida JN, Ohta M, SaekiT, Notohara K, Sumida T, Nakamura S.:
Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis,
so-called Mikulicz's disease.
Clin Immunol 156(1):9-18,2015
16. Takahashi H, Yamashita H, Kubota K, Miyata Y, Okasaki M, Morooka M, Takahashi Y, Kaneko H,Kano T, Mimori A.:
Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings
between elderly onset rheumatoid arthritis and polymyalgia rheumatica.
Mod Rheumatol 25(4):546-551,2015
17. Takahashi H, Tsuboi H, Kurata I, Takahashi H, Inoue S, Ebe H, Yokosawa M, Hagiwara S, Hirota T,Asashima H, Kaneko S, Kawaguchi H, Kurashima Y, Miki H, Umeda N, Kondo Y, Ogishima H,Suzuki T, Matsumoto I, Sumida T.:
Predictors of the response to treatment in acute lupus hemophagocytic syndrome.
Lupus 24(7):659-668,2015
18. Asanuma YF, Mimura T, Tsuboi H, Noma H, Miyoshi F, Yamamoto K, Sumida T.:
Nationwide epidemiological survey of 169 patients with adult Still's disease in Japan.
Mod Rheumatol 25(3):393-400,2015

19. Tahara M, Kondo Y, Yokosawa M, Tsuboi H, Takahashi S, Shibayama S, Matsumoto I, Sumida T.:
T-bet regulates differentiation of forkhead box protein 3+ regulatory T cells in programmed cell death1-deficient mice.
Clin Exp Immunol 179(2):197-209,2015
20. Yokosawa M, Tsuboi H, Nasu K, Hagiya C, Hagiwara S, Hirota T, Ebe H, Takahashi H, Asashima H,Kondo Y, Ogishima H, Suzuki T, Minami M, Bukawa H, Matsumoto I, Sumida T.:
Usefulness of MR imaging of the parotid glands in patients with secondary Sjögren's syndrome
associated with rheumatoid arthritis.
Mod Rheumatol 25(3):415-420,2015
21. Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Hagiya C,Asashima H, Takai C, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Hirata S, Saito K, Tanaka
Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:
Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoidarthritis: rheumatoid arthritis with orencia trial toward Sjögren's syndrome Endocrinopathy (ROSE)
trial-an open-label, one-year, prospective study-Interim analysis of 32 patients for 24 weeks.
Mod Rheumatol 25(2):187-193,2015
22. Suzuki T, Hirota T, Ogishima H, Umeda N, Kondo Y, Yokosawa M, Miki H, Tsuboi H, Matsumoto I,
Sumida T. Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRIevaluation for 2 years.
Int J Rheum Dis 18(1):108-110,2015
23. Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dörner T, Bootsma H, Tzioufas A, SolansLaqué R, Mandl T, Gottenberg JE, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S,Valesini G, Bartoloni E, Saraux A, Tomsic M, Sumida T, Nishiyama S, Caporali R, Kruize AA,Vollenweider C, Ravaud P, Vitali C, Mariette X, Bowman SJ; EULAR Sjögren's Task Force.:Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes(ESSPRI).
Ann Rheum Dis 74(5):859-866,2015
24. Gazal S, Sacre K, Allanore Y, Teruel M, Goodall AH; (The CARDIOGENICS consortium), Tohma S,Alfredsson L, Okada Y, Xie G, Constantin A, Balsa A, Kawasaki A, Nicaise P, Amos C, RodriguezRodriguez L, Chiocchia G, Boileau C, Zhang J, Vittecoq O, Barnetche T, Gonzalez Gay MA,Furukawa H, Cantagrel A, Le Loët X, Sumida T, Hurtado-Nedelec M, Richez C, Chollet-Martin S,Schaeverbeke T, Combe B, Khoryati L, Coustet B, El-Benna J, Siminovitch K, Plenge R, Padyukov L,Martin J, Tsuchiya N, Dieudé P.:
Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene.
Ann Rheum Dis 74(3):e19,2015
25. Iizuka M, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of
Sjögren's syndrome like sialadenitis.
Mod Rheumatol 25(1):158-160, 2015
26. Ebe H, Tsuboi H, Hagiya C, Takahashi H, Yokosawa M, Hagiwara S, Hirota T, Kurashima Y, TakaiC, Miki H, Asashima H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Chino Y, Matsumoto I, Sumida
T.:
Clinical features of patients with IgG4-related disease complicated with perivascular lesions.
Mod Rheumatol 25(1):105-109,2015